Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative assessment of RNA-dependent RNA polymerase (RdRp) inhibitors under clinical trials to control SARS-CoV2 using rigorous computational workflow. | RSC Adv | 2021 | 35478553 | PubTator, text mining | PubMed |
| Inward Outward Signaling in Ovarian Cancer: Morpho-Phospho-Proteomic Profiling Upon Application of Hypoxia and Shear Stress Characterizes the Adaptive Plasticity of OVCAR-3 and SKOV-3 Cells. | Front Oncol | 2021 | 35251951 | PubTator, text mining | PubMed |
| mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment. | Front Immunol | 2021 | 35250965 | PubTator, text mining | PubMed |
| A Comparative Study of the Communication Profile of Typically Developing Children and Children with Receptive-Expressive Language Disorders: A Parental Perceptive. | Clin Pract Epidemiol Ment Health | 2021 | 35136414 | PubTator, text mining | PubMed |
| Clinicopathological implications of lncRNAs, immunotherapy and DNA methylation in lung squamous cell carcinoma: a narrative review. | Transl Cancer Res | 2021 | 35116387 | PubTator, text mining | PubMed |
| Identification of key genes involved in tamoxifen-resistant breast cancer using bioinformatics analysis. | Transl Cancer Res | 2021 | 35116374 | PubTator, text mining | PubMed |
| RNA-Seq Transcriptome Analysis Provides Candidate Genes for Resistance to Tomato Leaf Curl New Delhi Virus in Melon. | Front Plant Sci | 2021 | 35116050 | PubTator, text mining | PubMed |
| Knockdown of NAA25 Suppresses Breast Cancer Progression by Regulating Apoptosis and Cell Cycle. | Front Oncol | 2021 | 35096568 | PubTator, text mining | PubMed |
| Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma. | Front Mol Biosci | 2021 | 35071320 | PubTator, text mining | PubMed |
| A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells. | Cells | 2021 | 35011576 | PubTator, text mining | PubMed |
| Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma. | Int J Mol Sci | 2021 | 35008802 | PubTator, text mining | PubMed |
| Hot Spot Mutagenesis Improves the Functional Expression of Unique Mammalian Odorant Receptors. | Int J Mol Sci | 2021 | 35008703 | PubTator, text mining | PubMed |
| The Impact of Iron Chelators on the Biology of Cancer Stem Cells. | Int J Mol Sci | 2021 | 35008527 | PubTator, text mining | PubMed |
| Inferring Homologous Recombination Deficiency of Ovarian Cancer From the Landscape of Copy Number Variation at Subchromosomal and Genetic Resolutions. | Front Oncol | 2021 | 34976815 | PubTator, text mining | PubMed |
| In Silico Sperm Proteome Analysis to Investigate DNA Repair Mechanisms in Varicocele Patients. | Front Endocrinol (Lausanne) | 2021 | 34975746 | PubTator, text mining | PubMed |
| Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription. | Clin Transl Med | 2021 | 34965023 | PubTator, text mining | PubMed |
| Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies. | Viruses | 2021 | 34960780 | PubTator, text mining | PubMed |
| CD105 expression is associated with invasive capacity in ovarian cancer and promotes invasiveness by inhibiting NDRG1 and regulating the epithelial-mesenchymal transition. | Am J Transl Res | 2021 | 34956466 | PubTator, text mining | PubMed |
| NDRG1 Activity in Fat Depots Is Associated With Type 2 Diabetes and Impaired Incretin Profile in Patients With Morbid Obesity. | Front Endocrinol (Lausanne) | 2021 | 34956089 | PubTator, text mining | PubMed |
| Biomedical Applications of Non-Small Cell Lung Cancer Spheroids. | Front Oncol | 2021 | 34950592 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=44